GLTO - Galecto stock rallies 25% on positive data for myelofibrosis drug
2023-12-21 16:40:39 ET
More on Galecto
- Galecto reduces workforce by 70%, explores potential strategic alternatives
- Seeking Alpha’s Quant Rating on Galecto
- Historical earnings data for Galecto
- Financial information for Galecto
For further details see:
Galecto stock rallies 25% on positive data for myelofibrosis drug